Global Med Technologies(R), Inc. to Present at 3rd Annual PIPEs Conference 2005 in New York City
October 21 2005 - 10:00AM
PR Newswire (US)
DENVER, Oct. 21 /PRNewswire-FirstCall/ -- Global Med
Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) ("Global
Med" or the "Company"), has accepted an invitation to present at
the 3rd Annual PIPEs Conference 2005 which is being held in New
York City at The Waldorf-Astoria Hotel on October 26 and 27. Global
Med will present at 9:00 a.m. and 2:00 p.m. on Wednesday, October
26, and also at 9:30 a.m. on Thursday, October 27. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) Global
Med's Chairman and CEO, Mick Ruxin, M.D., will provide a Company
overview, along with an update on Global Med's current operations
and new developments, using both an audio and visual arrangement.
Conference officials estimate this year's audience to be in excess
of 1,000 attendees, consisting primarily of investors, investment
bankers, attorneys, company executives and industry analysts active
in the small cap equity market. The conference includes
CLE-accredited workshops, roundtables and presentations from
leading industry professionals. Information about the event can be
found at http://www.thepipesconference.com/. About Global Med
Technologies, Inc. Global Med Technologies, Inc. is an
international e-Health, medical information technology company,
providing information management software products and services to
the healthcare industry. Its Wyndgate Technologies division is a
leading supplier of information management systems to U.S. and
international blood centers and hospital transfusion centers.
Current clients of Wyndgate's products and services manage more
than 3 million units of blood, or over 22% of the U.S. blood
supply, each year. Wyndgate's products are also being implemented
in Canada, the Caribbean and sub-Saharan Africa. Together, the
SafeTrace(R) donor management system and the SafeTrace Tx(R)*
advanced transfusion management system provide Vein-to-Vein(R)
tracking from donor collection to patient transfusion. For more
information about Global Med's products and services, please call
800-WYNDGATE or visit http://www.globalmedtech.com/,
http://www.peoplemed.com/ and http://www.wyndgate.com/. This news
release may include statements that constitute forward-looking
statements, usually containing the words "believe," "estimate,"
"project," "expects" or similar expressions. These statements are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements inherently involve risks and uncertainties that could
cause actual results to differ materially from the forward-looking
statements. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions
or changes after the date of this news release *Patent Pending
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Company, Michael I. Ruxin, M.D., of Global Med
Technologies, Inc., +1-303-238-2000; or Investors, John Nesbett or
Jordan Silverstein, both of The Investor Relations Group,
+1-212-825-3210, for Global Med Technologies, Inc. Web site:
http://www.globalmedtech.com/ http://www.peoplemed.com/
http://www.wyndgate.com/ http://www.thepipesconference.com/
Copyright